sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Bioactive Glass Market Size Study, by Product Outlook (Silicate-based glass, Phosphate-based glass, Borate-based glass), by Application Outlook (Medical, Dentistry, Cosmetics, Others) and Regional Forecasts 2022-2032

Global Bioactive Glass Market Size Study, by Product Outlook (Silicate-based...

Home / Categories / Healthcare
Global Bioactive Glass Market Size Study, by Product Outlook (Silicate-based glass, Phosphate-based glass, Borate-based glass), by Application Outlook (Medical, Dentistry, Cosmetics, Others) and Regional Forecasts 2022-2032
Global Bioactive Glass Market Size...
Report Code
RO1/103/2798

Publish Date
08/Aug/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Global Bioactive Glass Market is valued at approximately USD 25.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2024-2032. Bioactive glass, composed of silica, calcium oxide, and phosphorus oxide, represents a groundbreaking material in the realm of biocompatible and bioactive substances. When implanted, it forms a hydroxyapatite layer on its surface, which bonds seamlessly with bone tissue, making it indispensable in orthopaedic and dental applications such as bone grafts, coatings for implants, and dental fillings. Additionally, its applications extend to wound healing, tissue engineering, and drug delivery systems, significantly enhancing the body's natural repair processes. The intrinsic ability of bioactive glass to integrate with biological tissues positions it as a critical material in regenerative medicine, thereby driving market growth.

The market's expansion is underpinned by several key factors. Firstly, there is a burgeoning demand for dental care and cosmetic dentistry, propelled by increasing consumer awareness and the desire for enhanced oral aesthetics. Secondly, the rising prevalence of orthopedic disorders, including arthritis and osteoporosis, escalates the demand for orthopedic treatments and devices. Lastly, the growing incidence of dental conditions such as cavities and gum disease underscore the necessity for preventive and therapeutic dental care solutions. These factors collectively foster growth in the dental and orthopedic markets, spurring innovation in treatments, technologies, and patient care methodologies. As healthcare awareness continues to proliferate globally, the bioactive glass market is poised for sustained development, catering to the evolving needs of both patients and practitioners.

The high demand for dental care and cosmetic dentistry is a significant driver for the bioactive glass market. The prevalence of oral diseases, such as periodontal disease, often leads to tooth loss and infections, necessitating advanced dental care techniques like dental implants, bridges, and dentures. Technological advancements in dentistry, including teledentistry, digital x-rays, and lasers, alongside the inclusion of dental insurance in the National Health Insurance (NHI) bill, are further propelling market growth. However, stringent regulations and product recalls present challenges. Regulatory bodies enforce strict frameworks, and medical devices must undergo rigorous safety and efficacy evaluations before approval. Non-compliance can hinder new product launches, adversely affecting market growth.

In regional analysis, North America holds a dominant share in the bioactive glass market, largely due to the presence of key competitors in the US, robust economic growth, and the increasing adoption of bioactive glass in dental applications. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, driven by rising R&D investments in healthcare, increasing dental and orthopedic surgeries, lifestyle changes, and rising disposable incomes, all of which positively impact the market size in the region. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period 2024-2032

Major market players included in this report are:
Arthrex Inc.
Bonalive Biomaterials Ltd.
Curasan Inc.
Ferro Corp.
GlaxoSmithKline Plc
Johnson and Johnson Services Inc.
Koninklijke DSM NV
LASAK s.r.o.
Matexcel
Merck KGaA
The detailed segments and sub-segment of the market are explained below:
By Product Outlook:
Silicate-based glass
Phosphate-based glass
Borate-based glass
By Application Outlook:
Medical
Dentistry
Cosmetics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com